Haloacid dehalogenase like hydrolase domain containing 5 (HDHD5)

Haloacid dehalogenase like hydrolase domain containing 5 (HDHD5) is a mitochondrial enzyme predicted to participate in the biosynthesis of glycerophospholipids. It belongs to the haloacid dehalogenase (HAD) superfamily, specifically the class IIA subfamily of aspartate-nucleophile hydrolases. Mutations or disruptions in this gene have been associated with Cat Eye Syndrome and Noonan Syndrome 1[1][4][9]. Important clarification: "HDHD5 antisense RNA 1" does not appear in authoritative scientific databases; the entries and functions retrieved are for the protein-coding gene HDHD5. There is no established entity known as “HDHD5 antisense RNA 1” as a canonical therapeutic target, receptor, or functional molecule in reputable gene/protein databases as of the current knowledge cutoff. This query likely refers in error to a non-coding RNA possibly overlapping or related to the HDHD5 gene region, but no such functional antisense transcript is recognized or characterized as a target in genetic or drug discovery literature. Thus, this target name appears incorrect and the data provided refer strictly to the protein-coding gene HDHD5[1][9][4].

Other names

CECR5GC22M017150 (and related GeneCards identifiers)